Differentiation of grade II/III and grade IV glioma by combining “T1 contrast-enhanced brain perfusion imaging” and susceptibility-weighted quantitative imaging
- 31 October 2017
- journal article
- research article
- Published by Springer Nature in Neuroradiology
- Vol. 60 (1) , 43-50
Abstract
MRI is a useful method for discriminating low- and high-grade glioma using perfusion MRI and susceptibility-weighted imaging (SWI). The purpose of this study is to evaluate the usefulness of T1-perfusion MRI and SWI in discriminating among grade II, III, and IV gliomas.Keywords
This publication has 39 references indexed in Scilit:
- Understanding high grade glioma: Molecular mechanism, therapy and comprehensive managementCancer Letters, 2013
- Subcompartmentalization of extracellular extravascular space (EES) into permeability and leaky space with local arterial input function (AIF) results in improved discrimination between high‐ and low‐grade glioma using dynamic contrast‐enhanced (DCE) MRIJournal of Magnetic Resonance Imaging, 2013
- pROC: an open-source package for R and S+ to analyze and compare ROC curvesBMC Bioinformatics, 2011
- Interobserver variation of the histopathological diagnosis in clinical trials on glioma: a clinician’s perspectiveActa Neuropathologica, 2010
- Semiquantitative Assessment of Intratumoral Susceptibility Signals Using Non-Contrast-Enhanced High-Field High-Resolution Susceptibility-Weighted Imaging in Patients with Gliomas: Comparison with MR Perfusion ImagingAmerican Journal of Neuroradiology, 2009
- Prognostic Value of Perfusion MR Imaging of High-Grade Astrocytomas: Long-Term Follow-Up StudyAmerican Journal of Neuroradiology, 2008
- High-Resolution Contrast-Enhanced, Susceptibility-Weighted MR Imaging at 3T in Patients with Brain Tumors: Correlation with Positron-Emission Tomography and Histopathologic FindingsAmerican Journal of Neuroradiology, 2007
- The 2007 WHO Classification of Tumours of the Central Nervous SystemActa Neuropathologica, 2007
- Is the long‐term survival of patients with intracranial glioblastoma multiforme overstated?Cancer, 2003
- Dynamic, contrast‐enhanced perfusion MRI in mouse gliomas: Correlation with histopathologyMagnetic Resonance in Medicine, 2003